Our Philosophy

Solvotrin Therapeutics is an Irish healthcare company focused on developing innovative science for significant unmet clinic needs.

The company has ongoing research and development programmes involving salicylate and niacin pro-drugs in inflammatory skin diseases, such as psoriasis, as well as in cancer.

Solvotrin is also developing a range of medical foods (food for special medical purposes) for patients with disease-related malnutrition associated with iron. These patients need oral iron products that are better absorbed and better tolerated than currently marketed products.

Together with scientists at Trinity College Dublin Solvotrin has developed a groundbreaking new method of delivering iron which improves absorption and reduces negative gastro-intestinal side-effects. Active Iron was launched to the market in 2016 and is available in leading pharmacies throughout the UK and Ireland and online.

Active Iron is better absorbed than the gold standard ferrous sulfate. Also, the microencapsulated formulation results in less iron-related oxidative stress and damage in gut cells than ferrous sulfate. This can explain the low rate of adverse effects reported by users of Active Iron. These features make Active Iron a promising ingredient in medical food formulations.